查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830839

2025年全球神經再生療法市場報告

Neuroregeneration Therapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，神經再生療法市場發展迅速，預計將從2024年的99.8億美元成長到2025年的112.9億美元，複合年成長率達13.1%。這段歷史性成長時期可歸因於神經系統疾病盛行率的上升、全球老年人口的成長、研發投入的增加、政府支持和資金的增加以及學術界和產業界合作的加強。

預計未來幾年神經再生療法市場將快速成長，到2029年市場規模將達到182.3億美元，複合年成長率（CAGR）為12.7%。預測期內的成長可歸因於以下因素：對神經再生療法的需求不斷成長、細胞療法的普及、醫療保健需求的增加、生物技術投資的擴大以及人口老化的持續加劇。這段時期的主要趨勢包括：幹細胞治療方法的進步、個人化醫療的發展、神經退化性疾病基因編輯技術的創新、奈米技術在藥物傳遞中的應用以及製藥公司和生物技術公司之間日益密切的合作。

神經再生療法是一種旨在修復、再生或替換大腦、脊髓和周圍神經中受損的神經細胞和組織的醫療方法，最終目標是恢復因損傷、疾病或退化性疾病而喪失的神經功能。

神經再生療法的主要類型包括幹細胞療法、基因療法、藥物療法和神經刺激療法。幹細胞療法利用幹細胞修復、替換或再生體內受損或病變的細胞、組織或器官。這些治療方法採用多種技術，包括組織工程、顱腦和脊髓刺激、基於奈米技術的治療方法遞送以及生物材料開發，並且可以透過多種途徑給藥，包括口服、注射或植入。神經再生療法適用於多種適應症，包括脊髓損傷、創傷性腦損傷、中風、巴金森氏症、多發性硬化症、阿茲海默症和周邊神經損傷。這些治療方法的主要最終用戶包括醫院、臨床研究實驗室、學術機構以及製藥和生物技術公司。

美國在2025年春季突然提高關稅及其引發的貿易摩擦對製藥公司造成了嚴重衝擊。利潤豐厚的學名藥生產商尤其脆弱，一些公司不得不縮減低收益藥物的生產規模。生物技術公司也因關稅導致的專用試劑短缺而面臨臨床試驗延期。為因應這一局面，製藥業正在印度和歐洲擴大原料藥的生產，增加庫存，並遊說政府對基本藥物給予貿易豁免。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，提供神經再生療法市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢以及行業商機，為您在神經再生療法行業取得成功提供所需數據。本神經再生療法市場研究報告全面觀點了該行業的現狀和未來發展趨勢，為您提供所需的一切資訊。

預計未來幾年，神經系統疾病盛行率的不斷上升將推動神經再生療法市場的擴張。神經系統疾病會影響大腦、脊髓和周邊神經，損害正常的神經系統功能。長期接觸重金屬、殺蟲劑和工業化學物質會損害神經系統，增加神經退化性疾病的風險。神經再生療法透過修復或替換受損的神經細胞和組織，恢復喪失的功能，促進大腦、脊髓和神經的癒合，進而改善運動技能、感覺和生活品質。例如，總部位於英國的世界神經病學聯合會（World Federation of Neurology，一個由各國神經病學會組成的聯盟）於2023年10月報告稱，目前全球超過40%的人口患有神經系統疾病，預計到2050年，這一負擔將幾乎加倍。因此，神經系統疾病盛行率的不斷上升正在推動神經再生療法市場的成長。

不斷擴大的老齡人口預計也將推動神經再生療法市場的成長。人口老化是指人口結構的變化，導致社會老年人口比例不斷增加，進而帶來社會和醫療保健方面的挑戰。這一成長主要得益於醫療保健的進步和生活水準的提高，從而延長了預期壽命。神經再生療法在治療與年齡相關的神經系統疾病方面發揮關鍵作用，它透過修復受損的神經細胞、增強大腦功能和運動技能以及延緩認知衰退來提高整體生活品質。例如，英國議會研究機構－下議院圖書館在2024年7月發布的報告顯示，到2022年， 老齡化歲及以上人口將佔英國總人口的19%，約1270萬人。預計到2072年，這一數字將增至2,210萬人，佔總人口的27%。因此，不斷成長的老齡人口正在推動對神經再生療法的需求。

神經再生療法市場的公司也正在投資研發先進的解決方案，例如可吸收植入，以改善周邊神經再生和患者預後。可吸收植入是醫療設備，其設計目的是在完成治療後溶解並被人體吸收，因此無需手術取出。例如，2022年3月，美國生技公司Integra Lifesciences Holdings Corporation推出了Neuragen 3D神經引導基質，用於輔助修復周邊神經斷裂。該裝置將Integra的牛I型膠原蛋白與一種由多孔通道組成的創新內部基質相結合，該基質可引導雪旺細胞遷移並控制軸突生長，從而創造最佳的癒合環境。這項創新代表了周邊神經修復領域的一項重大進步，為外科醫生提供了治療短期至中期神經損傷的新方案，也是多年來旨在改善神經損傷患者功能恢復的研究成果。

神經再生療法市場由提供生物材料植入服務、神經修復手術以及諮詢和支持服務等服務的營業單位所獲得的收益所構成。市場價值還包括服務提供者銷售或包含在其服務產品中的任何相關商品的價值。神經再生療法市場還包括生物材料、神經刺激和神經調控設備、藥品以及神經電極陣列的銷售。該市場的價值為“出廠價”，即商品製造商或創造者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品創造者提供的任何相關服務的價值。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球神經再生療法：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球神經再生療法市場：成長率分析
  • 全球神經再生療法市場表現：規模與成長，2019-2024年
  • 全球神經再生療法市場預測：規模與成長，2024-2029年，2034年
  • 全球神經再生療法：潛在市場規模 (TAM)

第6章 市場細分

  • 全球神經再生療法市場：依神經再生療法類型、表現和預測分類，2019-2024年、2024-2029年、2034年
  • 幹細胞療法
  • 基因治療
  • 藥物治療
  • 神經刺激療法
  • 其他類型的神經再生療法
  • 全球神經再生療法市場：依技術、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 組織工程
  • 顱脊髓刺激
  • 奈米技術在藥物傳遞的應用
  • 生物材料開發
  • 全球神經再生療法市場依給藥方式分類：績效及預測，2019-2024年、2024-2029年、2034年
  • 口服
  • 注射
  • 嵌入式
  • 其他管理方法
  • 全球神經再生療法市場：依適應症、療效和預測分類，2019-2024年、2024-2029年、2034年
  • 脊髓損傷
  • 創傷性腦損傷
  • 中風
  • 帕金森氏症
  • 多發性硬化症
  • 阿茲海默症
  • 周邊神經損傷
  • 其他跡象
  • 全球神經再生療法市場按最終用戶、表現和預測分類，2019-2024年、2024-2029年、2034年
  • 醫院
  • 臨床研究所
  • 學術機構
  • 製藥和生物技術公司
  • 全球神經再生療法市場：依幹細胞療法（按類型）細分、績效及預測，2019-2024年、2024-2029年、2034年
  • 胚胎幹細胞治療
  • 間質幹細胞療法
  • 神經幹細胞療法
  • 誘導性多功能幹細胞療法
  • 造血幹細胞療法
  • 全球神經再生療法市場：按基因療法類型、表現和預測進行細分，2019-2024年、2024-2029年、2034年
  • 體內基因治療
  • 體外基因治療
  • 基於病毒載體的基因治療
  • 基於非病毒載體的基因治療
  • 基因組編輯基因療法
  • 全球神經再生療法市場：按治療類型細分、表現和預測（2019-2024年、2024-2029年、2034年）
  • 神經保護藥物
  • 基於神經營養因子的藥物
  • 抗發炎藥物
  • 抗氧化劑
  • 膽鹼酯酶抑制劑
  • 全球神經再生療法市場：按神經刺激療法（類型）細分、表現和預測（2019-2024 年、2024-2029 年、2034 年）
  • 深部腦部刺激
  • 經顱磁刺激
  • 迷走神經刺激
  • 脊髓刺激
  • 經顱直流電刺激
  • 全球神經再生療法市場：細分：其他類型的神經再生療法、績效及預測，2019-2024年、2024-2029年、2034年
  • 基於奈米技術的治療
  • 基於外泌體的治療方法
  • 基於生物材料的治療方法
  • 電磁場療法
  • 高壓氧氣療法

第7章 區域和國家分析

  • 全球神經再生療法市場：按地區、績效和預測分類，2019-2024年、2024-2029年、2034年
  • 全球神經再生療法市場：國家、績效及預測，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 神經再生療法市場：競爭格局
  • 神經再生療法市場：公司概況
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Novartis International AG
  • Stryker Corporation
  • Biogen Inc.
  • Synovis Life Technologies Inc.
  • Integra LifeSciences Holdings Corporation
  • AxoGen Inc.
  • Denali Therapeutics Inc.
  • Aspen Neuroscience Inc.
  • Neurona Therapeutics Inc.
  • Lineage Cell Therapeutics Inc.
  • Checkpoint Surgical Inc.
  • Stemedica Cell Technologies Inc.
  • Polyganics BV
  • Epineuron Technologies Inc.
  • NeuExcell Therapeutics Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年神經再生療法市場：提供新機會的國家
  • 2029年神經再生療法市場：蘊藏新機會的細分市場
  • 2029年神經再生療法市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r37829

Neuroregeneration therapy refers to medical approaches aimed at repairing, regenerating, or replacing damaged neurons and neural tissues in the brain, spinal cord, or peripheral nerves, with the ultimate goal of restoring neurological functions lost due to injury, disease, or degenerative conditions.

The major types of neuroregeneration therapy include stem cell therapy, gene therapy, pharmacological therapy, neurostimulation therapy, and others. Stem cell therapy involves the use of stem cells to repair, replace, or regenerate damaged or diseased cells, tissues, or organs in the body. These therapies employ a range of technologies such as tissue engineering, cranial and spinal stimulation, nanotechnology-based drug delivery, and biomaterials development, and can be administered through various modes including oral, injectable, implantable, and others. Neuroregeneration therapies are applied across multiple indications, including spinal cord injury, traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, Alzheimer's disease, and peripheral nerve injury. Key end users of these therapies include hospitals, clinical research institutes, academic institutions, and pharmaceutical and biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The neuroregeneration therapy market research report is one of a series of new reports from The Business Research Company that provides neuroregeneration therapy market statistics, including the neuroregeneration therapy industry global market size, regional shares, competitors with the neuroregeneration therapy market share, detailed neuroregeneration therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the neuroregeneration therapy industry. This neuroregeneration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neuroregeneration therapy market size has grown rapidly in recent years. It will grow from $9.98 billion in 2024 to $11.29 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth during the historic period can be attributed to the rising prevalence of neurological disorders, the global increase in the geriatric population, expanding investments in research and development, greater government support and funding, and the growing collaborations between academia and industry.

The neuroregeneration therapy market size is expected to see rapid growth in the next few years. It will grow to $18.23 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to the increasing demand for neuroregeneration therapies, the rising adoption of cell therapies, growing healthcare needs, expanding investments in biotechnology, and the continued rise in the aging population. Key trends expected during this period include advancements in stem cell-based therapies, the development of personalized medicine, innovations in gene editing for neurodegenerative diseases, the application of nanotechnology in drug delivery, and the evolution of pharma-biotech collaborations.

The growing prevalence of neurological disorders is anticipated to drive the expansion of the neuroregeneration therapy market in the coming years. Neurological disorders affect the brain, spinal cord, or peripheral nerves, impairing normal nervous system functions. One of the key contributors to the rise in such conditions is exposure to environmental toxins, as prolonged contact with heavy metals, pesticides, and industrial chemicals can damage the nervous system and increase the risk of neurodegenerative diseases. Neuroregeneration therapy addresses these disorders by repairing or replacing damaged neurons and tissues, restoring lost functions, and promoting healing in the brain, spinal cord, and nerves to improve mobility, sensation, and quality of life. For example, in October 2023, the World Federation of Neurology, a UK-based association of national neurological societies, reported that over 40% of the global population currently suffers from a neurological condition, with this burden projected to nearly double by 2050. Consequently, the increasing prevalence of neurological disorders is fueling the growth of the neuroregeneration therapy market.

The expanding aging population is also expected to accelerate the growth of the neuroregeneration therapy market. An aging population refers to the demographic shift in which the proportion of older individuals in society rises, creating social and healthcare challenges. This growth is driven by longer life expectancy resulting from advancements in healthcare and improved living standards. Neuroregeneration therapy plays a vital role in addressing age-related neurological conditions by repairing damaged nerve cells, enhancing brain function and mobility, and slowing cognitive decline to improve overall quality of life. For instance, in July 2024, the House of Commons Library, a UK-based parliamentary research service, reported that in 2022, individuals aged 65 and over accounted for 19% of the UK's total population, around 12.7 million people. This figure is projected to rise to 22.1 million, representing 27% of the population, by 2072. As a result, the increasing elderly population is boosting demand for neuroregeneration therapies.

Companies in the neuroregeneration therapy market are also investing in advanced solutions such as resorbable implants to improve peripheral nerve regeneration and patient outcomes. Resorbable implants are medical devices designed to dissolve and be absorbed by the body after serving their purpose, thereby eliminating the need for surgical removal. For example, in March 2022, Integra LifeSciences Holdings Corporation, a US-based biotechnology company, introduced the NeuraGen 3D Nerve Guide Matrix to aid in repairing peripheral nerve discontinuities. The device combines Integra's bovine type 1 collagen with an innovative inner matrix of porous channels, creating an optimal healing environment by guiding Schwann cell migration and directing axonal growth. This innovation marked a major step forward in peripheral nerve repair, offering surgeons a new solution for short- to mid-gap nerve injuries and representing the result of years of research aimed at improving functional recovery for patients with nerve damage.

Major players in the neuroregeneration therapy market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis International AG, Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics B.V., Epineuron Technologies Inc., NeuExcell Therapeutics Inc.

North America was the largest region in the neuroregeneration therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuroregeneration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neuroregeneration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroregeneration therapy market consists of revenues earned by entities by providing services such as biomaterial implantation services, surgical interventions for nerve repair, and consulting and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroregeneration therapy market also includes sales of biomaterials, neurostimulation and neuromodulation devices, pharmaceuticals, and neural electrode arrays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroregeneration Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroregeneration therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuroregeneration therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuroregeneration therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type Of Neuroregeneration Therapy: Stem Cell Therapy; Gene Therapy; Pharmacological Therapy; Neurostimulation Therapy; Other Types Of Neuroregeneration Therapy
  • 2) By Technology: Tissue Engineering; Cranial And Spinal Stimulation; Nanotechnology In Drug Delivery; Biomaterials Development
  • 3) By Mode Of Administration: Oral; Injectable; Implantable; Other Modes Of Administration
  • 4) By Indication: Spinal Cord Injury; Traumatic Brain Injury; Stroke; Parkinson's Disease; Multiple Sclerosis; Alzheimer's Disease; Peripheral Nerve Injury; Other Indications
  • 5) By End-User: Hospitals; Clinical Research Institutes; Academic Institutions; Pharmaceutical And Biotechnology Companies
  • Subsegment:
  • 1) By Stem Cell Therapy: Embryonic Stem Cell Therapy; Mesenchymal Stem Cell Therapy; Neural Stem Cell Therapy; Induced Pluripotent Stem Cell Therapy; Hematopoietic Stem Cell Therapy
  • 2) By Gene Therapy: In Vivo Gene Therapy; Ex Vivo Gene Therapy; Viral Vector Based Gene Therapy; Non Viral Vector Based Gene Therapy; Genome Editing Gene Therapy
  • 3) By Pharmacological Therapy: Neuroprotective Drugs; Neurotrophic Factor Based Drugs; Anti Inflammatory Drugs; Antioxidant Drugs; Cholinesterase Inhibitors
  • 4) By Neurostimulation Therapy: Deep Brain Stimulation; Transcranial Magnetic Stimulation; Vagus Nerve Stimulation; Spinal Cord Stimulation; Transcranial Direct Current Stimulation
  • 5) By Other Types Of Neuroregeneration Therapy: Nanotechnology Based Therapy; Exosome Based Therapy; Biomaterial Based Therapy; Electromagnetic Field Therapy; Hyperbaric Oxygen Therapy
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.; AstraZeneca PLC; Novartis International AG; Stryker Corporation; Biogen Inc.; Synovis Life Technologies Inc.; Integra LifeSciences Holdings Corporation; AxoGen Inc.; Denali Therapeutics Inc.; Aspen Neuroscience Inc.; Neurona Therapeutics Inc.; Lineage Cell Therapeutics Inc.; Checkpoint Surgical Inc.; Stemedica Cell Technologies Inc.; Polyganics B.V.; Epineuron Technologies Inc.; NeuExcell Therapeutics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neuroregeneration Therapy Market Characteristics

3. Neuroregeneration Therapy Market Trends And Strategies

4. Neuroregeneration Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neuroregeneration Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neuroregeneration Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neuroregeneration Therapy Market Growth Rate Analysis
  • 5.4. Global Neuroregeneration Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neuroregeneration Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neuroregeneration Therapy Total Addressable Market (TAM)

6. Neuroregeneration Therapy Market Segmentation

  • 6.1. Global Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stem Cell Therapy
  • Gene Therapy
  • Pharmacological Therapy
  • Neurostimulation Therapy
  • Other Types Of Neuroregeneration Therapy
  • 6.2. Global Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Engineering
  • Cranial And Spinal Stimulation
  • Nanotechnology In Drug Delivery
  • Biomaterials Development
  • 6.3. Global Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Injectable
  • Implantable
  • Other Modes Of Administration
  • 6.4. Global Neuroregeneration Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Cord Injury
  • Traumatic Brain Injury
  • Stroke
  • Parkinson's Disease
  • Multiple Sclerosis
  • Alzheimer's Disease
  • Peripheral Nerve Injury
  • Other Indications
  • 6.5. Global Neuroregeneration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinical Research Institutes
  • Academic Institutions
  • Pharmaceutical And Biotechnology Companies
  • 6.6. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embryonic Stem Cell Therapy
  • Mesenchymal Stem Cell Therapy
  • Neural Stem Cell Therapy
  • Induced Pluripotent Stem Cell Therapy
  • Hematopoietic Stem Cell Therapy
  • 6.7. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In Vivo Gene Therapy
  • Ex Vivo Gene Therapy
  • Viral Vector Based Gene Therapy
  • Non-Viral Vector Based Gene Therapy
  • Genome Editing Gene Therapy
  • 6.8. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Pharmacological Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neuroprotective Drugs
  • Neurotrophic Factor Based Drugs
  • Anti Inflammatory Drugs
  • Antioxidant Drugs
  • Cholinesterase Inhibitors
  • 6.9. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Neurostimulation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deep Brain Stimulation
  • Transcranial Magnetic Stimulation
  • Vagus Nerve Stimulation
  • Spinal Cord Stimulation
  • Transcranial Direct Current Stimulation
  • 6.10. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Other Types Of Neuroregeneration Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nanotechnology Based Therapy
  • Exosome Based Therapy
  • Biomaterial Based Therapy
  • Electromagnetic Field Therapy
  • Hyperbaric Oxygen Therapy

7. Neuroregeneration Therapy Market Regional And Country Analysis

  • 7.1. Global Neuroregeneration Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neuroregeneration Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neuroregeneration Therapy Market

  • 8.1. Asia-Pacific Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neuroregeneration Therapy Market

  • 9.1. China Neuroregeneration Therapy Market Overview
  • 9.2. China Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neuroregeneration Therapy Market

  • 10.1. India Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neuroregeneration Therapy Market

  • 11.1. Japan Neuroregeneration Therapy Market Overview
  • 11.2. Japan Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neuroregeneration Therapy Market

  • 12.1. Australia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neuroregeneration Therapy Market

  • 13.1. Indonesia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neuroregeneration Therapy Market

  • 14.1. South Korea Neuroregeneration Therapy Market Overview
  • 14.2. South Korea Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neuroregeneration Therapy Market

  • 15.1. Western Europe Neuroregeneration Therapy Market Overview
  • 15.2. Western Europe Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neuroregeneration Therapy Market

  • 16.1. UK Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neuroregeneration Therapy Market

  • 17.1. Germany Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neuroregeneration Therapy Market

  • 18.1. France Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neuroregeneration Therapy Market

  • 19.1. Italy Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neuroregeneration Therapy Market

  • 20.1. Spain Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neuroregeneration Therapy Market

  • 21.1. Eastern Europe Neuroregeneration Therapy Market Overview
  • 21.2. Eastern Europe Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neuroregeneration Therapy Market

  • 22.1. Russia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neuroregeneration Therapy Market

  • 23.1. North America Neuroregeneration Therapy Market Overview
  • 23.2. North America Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neuroregeneration Therapy Market

  • 24.1. USA Neuroregeneration Therapy Market Overview
  • 24.2. USA Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neuroregeneration Therapy Market

  • 25.1. Canada Neuroregeneration Therapy Market Overview
  • 25.2. Canada Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neuroregeneration Therapy Market

  • 26.1. South America Neuroregeneration Therapy Market Overview
  • 26.2. South America Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neuroregeneration Therapy Market

  • 27.1. Brazil Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neuroregeneration Therapy Market

  • 28.1. Middle East Neuroregeneration Therapy Market Overview
  • 28.2. Middle East Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neuroregeneration Therapy Market

  • 29.1. Africa Neuroregeneration Therapy Market Overview
  • 29.2. Africa Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neuroregeneration Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Neuroregeneration Therapy Market Competitive Landscape
  • 30.2. Neuroregeneration Therapy Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Neuroregeneration Therapy Market Other Major And Innovative Companies

  • 31.1. Novartis International AG
  • 31.2. Stryker Corporation
  • 31.3. Biogen Inc.
  • 31.4. Synovis Life Technologies Inc.
  • 31.5. Integra LifeSciences Holdings Corporation
  • 31.6. AxoGen Inc.
  • 31.7. Denali Therapeutics Inc.
  • 31.8. Aspen Neuroscience Inc.
  • 31.9. Neurona Therapeutics Inc.
  • 31.10. Lineage Cell Therapeutics Inc.
  • 31.11. Checkpoint Surgical Inc.
  • 31.12. Stemedica Cell Technologies Inc.
  • 31.13. Polyganics B.V.
  • 31.14. Epineuron Technologies Inc.
  • 31.15. NeuExcell Therapeutics Inc.

32. Global Neuroregeneration Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neuroregeneration Therapy Market

34. Recent Developments In The Neuroregeneration Therapy Market

35. Neuroregeneration Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Neuroregeneration Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neuroregeneration Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neuroregeneration Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer